| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10130580 | ARBOR PHARMS LLC | Taste-masked pharmaceutical compositions |
Apr, 2024
(6 months from now) | |
| US10441554 | ARBOR PHARMS LLC | Oral amphetamine composition |
Mar, 2037
(13 years from now) | |
| US11160772 | ARBOR PHARMS LLC | Oral amphetamine composition |
Mar, 2037
(13 years from now) | |
Evekeo Odt is owned by Arbor Pharms Llc.
Evekeo Odt contains Amphetamine Sulfate.
Evekeo Odt has a total of 3 drug patents out of which 0 drug patents have expired.
Evekeo Odt was authorised for market use on 30 January, 2019.
Evekeo Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Evekeo Odt are possible to be released after 10 March, 2037.
Drugs and Companies using AMPHETAMINE SULFATE ingredient
Market Authorisation Date: 30 January, 2019
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
EVEKEO ODT family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic